3-Methyl-5-phenylpent-2-enenitrile
Common Name: |
3-Methyl-5-phenylpent-2-enenitrile |
IUPAC Name: |
(E)-3-methyl-5-phenylpent-2-enenitrile |
Molecular Formula: |
C12H20O2 |
SMILES: |
CC(=CC#N)CCC1=CC=CC=C1 |
Inchi: |
1S/C12H13N/c1-11(9-10-13)7-8-12-5-3-2-4-6-12/h2-6,9H,7-8H2,1H3/b11-9+ |
Inchi Key: |
QELCXXZZKSRBET-PKNBQFBNSA-N |
Cas No: |
53243-60-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
196.29 |
Mass (g/mol) |
171.105 |
Molar Refractivity |
58.91 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
18.46 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
308.00 to 310.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.001 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.67 |
LogP |
3.089 |
iLOGP |
2.98 |
XLOGP3 |
3.19 |
WLOGP |
3.05 |
MLOGP |
2.25 |
ESOL Log S |
-2.80 |
ESOL Solubility (mg/ml) |
0.309 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.25 |
Ali Solubility (mg/ml) |
0.11 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.12 |
Silicos-IT Solubility (mg/ml) |
1.5 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.23 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.512 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.187 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |